About ReWalk Robotics (NASDAQ:RWLK)
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:RWLK
CUSIPN/A
Phone972-4959-0123
Debt
Debt-to-Equity Ratio2.41%
Current Ratio2.15%
Quick Ratio1.78%
Price-To-Earnings
Trailing P/E Ratio-1.11
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$7.75 million
Price / Sales4.26
Cash FlowN/A
Price / CashN/A
Book Value$0.13 per share
Price / Book8.46
Profitability
EPS (Most Recent Fiscal Year)($0.99)
Net Income$-24,710,000.00
Net Margins-318.81%
Return on Equity-678.44%
Return on Assets-85.08%
Miscellaneous
Employees65
Outstanding Shares30,010,000
ReWalk Robotics (NASDAQ:RWLK) Frequently Asked Questions
What is ReWalk Robotics' stock symbol?
ReWalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."
How were ReWalk Robotics' earnings last quarter?
ReWalk Robotics (NASDAQ:RWLK) posted its earnings results on Thursday, March, 8th. The medical device company reported ($0.20) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.26) by $0.06. The medical device company had revenue of $1.52 million for the quarter, compared to analyst estimates of $1.76 million. ReWalk Robotics had a negative return on equity of 678.44% and a negative net margin of 318.81%. View ReWalk Robotics' Earnings History.
When is ReWalk Robotics' next earnings date?
What price target have analysts set for RWLK?
5 brokerages have issued 1 year target prices for ReWalk Robotics' shares. Their forecasts range from $1.00 to $5.00. On average, they anticipate ReWalk Robotics' stock price to reach $2.80 in the next twelve months. View Analyst Ratings for ReWalk Robotics.
What are Wall Street analysts saying about ReWalk Robotics stock?
Here are some recent quotes from research analysts about ReWalk Robotics stock:
- 1. Canaccord Genuity analysts commented, "We maintain our BUY rating on ReWalk Robotics following Q4/17 results. ReWalk reported revenues of $1.5M, below CG/consensus of $2.1M/$1.9M. Although the shipment of 23 systems was well below our expectation for 42 systems, ReWalk sales benefited from a favorable mix of system purchases and rental conversions in the quarter. Despite the weaker than anticipated system placements, we were encouraged to see another quarter of strong demand and another positive coverage decision with reimbursement through Italy’s worker’s compensation group. While commercial unit placements continue to be lumpy Q/Q we continue to view the broader pipeline (Restore soft suit for stroke) positively in the H2/18 and beyond. Positive momentum in demand and reimbursement decisions: In Q4/17 the company placed 23 total units, down from 39 Y/Y but up Q/Q from 16." (3/12/2018)
- 2. According to Zacks Investment Research, "ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. The Company's exoskeletons allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. It offers ReWalk Personal for everyday use to individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy to individuals with lower limb disabilities in the clinical rehabilitation environment. ReWalk Robotics Ltd. is headquartered in Yokneam Ilit, Israel. " (1/4/2018)
Who are some of ReWalk Robotics' key competitors?
Who are ReWalk Robotics' key executives?
ReWalk Robotics' management team includes the folowing people:
- Mr. Lawrence J Jasinski, Chief Exec. Officer and Director (Age 61)
- Mr. Ofir Koren, GM & VP of R&D and Regulatory (Age 48)
- Mr. Ori Gon, Chief Financial Officer (Age 36)
- Ms. Miri Pariente, VP of QA & Operations (Age 41)
- Mr. Loren Wass, VP of Sales & Reimbursement
Has ReWalk Robotics been receiving favorable news coverage?
Headlines about RWLK stock have trended positive this week, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. ReWalk Robotics earned a news impact score of 0.42 on Accern's scale. They also gave news headlines about the medical device company an impact score of 43.95 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of ReWalk Robotics?
Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ReWalk Robotics' stock price today?
One share of RWLK stock can currently be purchased for approximately $1.10.
How big of a company is ReWalk Robotics?
ReWalk Robotics has a market capitalization of $31.51 million and generates $7.75 million in revenue each year. The medical device company earns $-24,710,000.00 in net income (profit) each year or ($0.99) on an earnings per share basis. ReWalk Robotics employs 65 workers across the globe.
How can I contact ReWalk Robotics?
ReWalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123.
MarketBeat Community Rating for ReWalk Robotics (RWLK)
MarketBeat's community ratings are surveys of what our community members think about ReWalk Robotics and other stocks. Vote "Outperform" if you believe RWLK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RWLK will underperform the S&P 500 over the long term. You may vote once every thirty days.
ReWalk Robotics (NASDAQ:RWLK) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for ReWalk Robotics in the last 12 months. Their average twelve-month price target is $2.80, suggesting that the stock has a possible upside of 154.55%. The high price target for RWLK is $5.00 and the low price target for RWLK is $1.00. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.60 | 2.60 | 2.60 | 2.50 |
| Ratings Breakdown: | 1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $2.80 | $2.80 | $3.10 | $4.6250 |
| Price Target Upside: | 154.55% upside | 124.00% upside | 174.34% upside | 198.39% upside |
ReWalk Robotics (NASDAQ:RWLK) Consensus Price Target History
ReWalk Robotics (NASDAQ:RWLK) Analyst Ratings History
Show:
(Data available from 4/25/2016 forward)
ReWalk Robotics (NASDAQ:RWLK) Earnings History and Estimates Chart
ReWalk Robotics (NASDAQ RWLK) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/2/2018 | | ($0.26) | | | | | N/A |  |
| 3/8/2018 | Before Market | ($0.26) | ($0.20) | $1.76 million | $1.52 million | View | Listen | |
| 11/2/2017 | Q3 | ($0.32) | ($0.22) | $1.63 million | $1.70 million | View | N/A | |
| 8/3/2017 | 6/30/2017 | ($0.35) | ($0.29) | $1.71 million | $2.01 million | View | Listen | |
| 5/4/2017 | 3/31/2017 | ($0.43) | ($0.33) | $2.45 million | $2.50 million | View | Listen | |
| 2/17/2017 | Q4 2016 | | ($0.54) | $2.14 million | $1.59 million | View | N/A | |
| 11/3/2016 | Q316 | ($0.59) | ($0.62) | $1.25 million | $1.40 million | View | Listen | |
| 8/4/2016 | Q216 | ($0.53) | ($0.64) | $1.95 million | $0.82 million | View | Listen | |
| 5/5/2016 | Q116 | ($0.60) | ($0.48) | $1.56 million | $2.06 million | View | Listen | |
| 2/25/2016 | Q415 | ($0.53) | ($0.62) | $1.41 million | $1.30 million | View | Listen | |
| 11/5/2015 | Q315 | ($0.49) | ($0.53) | $1.04 million | $1.20 million | View | Listen | |
| 8/6/2015 | Q215 | ($0.40) | ($0.48) | $1.58 million | $0.61 million | View | Listen | |
| 5/7/2015 | Q1 | ($0.38) | ($0.48) | $2.20 million | $0.64 million | View | Listen | |
| 2/12/2015 | Q414 | ($0.49) | ($0.46) | $2.44 million | $1.50 million | View | Listen | |
| 11/13/2014 | Q3 | ($0.28) | ($1.34) | $1.58 million | $1.50 million | View | Listen | |
(Earnings results data provided by Zacks Investment Research)
ReWalk Robotics (NASDAQ:RWLK) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
ReWalk Robotics (NASDAQ RWLK) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 2.51%
ReWalk Robotics (NASDAQ RWLK) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/26/2018 | Lawrence J Jasinski | CEO | Sell | 415 | $1.15 | $477.25 | | |
| 11/27/2017 | Lawrence J Jasinski | CEO | Sell | 428 | $1.15 | $492.20 | | |
| 10/10/2017 | Jodi Gricci | VP | Sell | 67 | $1.50 | $100.50 | | |
| 8/28/2017 | Lawrence J Jasinski | CEO | Sell | 413 | $1.65 | $681.45 | | |
| 7/10/2017 | Jodi Gricci | VP | Sell | 118 | $1.45 | $171.10 | | |
| 6/27/2017 | Scp Vitalife Partners Ii Lp | Major Shareholder | Sell | 65,218 | $3.05 | $198,914.90 | | |
| 6/27/2017 | Wayne Weisman | Director | Sell | 87,000 | $3.05 | $265,350.00 | | |
| 6/26/2017 | Jeff Dykan | Director | Sell | 37,030 | $3.00 | $111,090.00 | | |
| 6/26/2017 | Scp Vitalife Partners (Israel) | Major Shareholder | Sell | 9,271 | $3.00 | $27,813.00 | | |
| 5/22/2017 | Jodi Gricci | VP | Sell | 266 | $1.15 | $305.90 | | |
| 5/22/2017 | Kevin Hershberger | CFO | Sell | 980 | $1.15 | $1,127.00 | | |
| 8/16/2016 | Scp Vitalife Partners (Israel) | Major Shareholder | Sell | 25,038 | $6.37 | $159,492.06 | | |
| 8/16/2016 | Wayne Weisman | Director | Sell | 100,000 | $6.37 | $637,000.00 | | |
| 6/3/2016 | Scp Vitalife Partners (Israel) | Major Shareholder | Sell | 4,772 | $7.89 | $37,651.08 | | |
| 6/3/2016 | Wayne Weisman | Director | Sell | 19,060 | $7.89 | $150,383.40 | | |
| 6/1/2016 | Jeff Dykan | Director | Sell | 11,370 | $7.74 | $88,003.80 | | |
| 6/1/2016 | Scp Vitalife Partners (Israel) | Major Shareholder | Sell | 2,847 | $7.74 | $22,035.78 | | |
| 5/26/2016 | Jeff Dykan | Director | Sell | 27,022 | $8.69 | $234,821.18 | | |
| 5/26/2016 | Scp Vitalife Partners Ii Lp | Major Shareholder | Sell | 20,256 | $8.69 | $176,024.64 | | |
| 5/24/2016 | Scp Vitalife Partners (Israel) | Major Shareholder | Sell | 350 | $8.99 | $3,146.50 | | |
| 5/24/2016 | Wayne Weisman | Director | Sell | 1,400 | $8.99 | $12,586.00 | | |
| 5/23/2016 | Jeff Dykan | Director | Sell | 1,200 | $9.00 | $10,800.00 | | |
| 5/23/2016 | Scp Vitalife Partners Ii Lp | Major Shareholder | Sell | 900 | $9.00 | $8,100.00 | | |
| 5/20/2016 | Scp Vitalife Partners (Israel) | Major Shareholder | Sell | 4,043 | $9.09 | $36,750.87 | | |
| 5/20/2016 | Wayne Weisman | Director | Sell | 16,148 | $9.09 | $146,785.32 | | |
| 3/7/2016 | Wayne Weisman | Director | Sell | 3,002 | $8.33 | $25,006.66 | | |
| 3/4/2016 | Wayne Weisman | Director | Sell | 6,999 | $8.71 | $60,961.29 | | |
| 1/15/2016 | Jeff Dykan | Director | Sell | 50,000 | $10.30 | $515,000.00 | | |
| 1/15/2016 | Scp Vitalife Partners Ii Lp | Major Shareholder | Sell | 37,481 | $10.30 | $386,054.30 | | |
(Data available from 1/1/2013 forward)
ReWalk Robotics (NASDAQ RWLK) News Headlines
| Source: |
|
ReWalk Robotics (NASDAQ:RWLK) SEC Filings
This page is loading this company's SEC Filings. Please wait...
ReWalk Robotics (NASDAQ:RWLK) Income Statement, Balance Sheet and Cash Flow Statement
ReWalk Robotics (NASDAQ RWLK) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
